Standard
Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. / Nygaard, Ulrikka; Holm, Mette; Bohnstedt, Cathrine; Chai, Qing; Schmidt, Lisbeth Samso; Hartling, Ulla Birgitte; Petersen, Jens Jakob Herrche; Thaarup, Jesper; Bjerre, Jesper; Vejlstrup, Niels Grove; Juul, Klaus; Stensballe, Lone Graff.
In:
Pediatric Infectious Disease Journal, Vol. 41, No. 1, 01.2022, p. E25-E28.
Research output: Contribution to journal › Letter › Research › peer-review
Harvard
Nygaard, U, Holm, M
, Bohnstedt, C, Chai, Q
, Schmidt, LS, Hartling, UB
, Petersen, JJH, Thaarup, J, Bjerre, J, Vejlstrup, NG, Juul, K
& Stensballe, LG 2022, '
Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents',
Pediatric Infectious Disease Journal, vol. 41, no. 1, pp. E25-E28.
https://doi.org/10.1097/INF.0000000000003389
APA
Nygaard, U., Holm, M.
, Bohnstedt, C., Chai, Q.
, Schmidt, L. S., Hartling, U. B.
, Petersen, J. J. H., Thaarup, J., Bjerre, J., Vejlstrup, N. G., Juul, K.
, & Stensballe, L. G. (2022).
Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents.
Pediatric Infectious Disease Journal,
41(1), E25-E28.
https://doi.org/10.1097/INF.0000000000003389
Vancouver
Nygaard U, Holm M
, Bohnstedt C, Chai Q
, Schmidt LS, Hartling UB et al.
Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents.
Pediatric Infectious Disease Journal. 2022 Jan;41(1):E25-E28.
https://doi.org/10.1097/INF.0000000000003389
Author
Nygaard, Ulrikka ; Holm, Mette ; Bohnstedt, Cathrine ; Chai, Qing ; Schmidt, Lisbeth Samso ; Hartling, Ulla Birgitte ; Petersen, Jens Jakob Herrche ; Thaarup, Jesper ; Bjerre, Jesper ; Vejlstrup, Niels Grove ; Juul, Klaus ; Stensballe, Lone Graff. / Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. In: Pediatric Infectious Disease Journal. 2022 ; Vol. 41, No. 1. pp. E25-E28.
Bibtex
@article{824cebbe92a04838b9c39dfbde25431c,
title = "Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents",
abstract = "In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.",
keywords = "mRNA COVID-19 vaccine, myopericarditis, adolescents Accepted for publication October 10, 2021",
author = "Ulrikka Nygaard and Mette Holm and Cathrine Bohnstedt and Qing Chai and Schmidt, {Lisbeth Samso} and Hartling, {Ulla Birgitte} and Petersen, {Jens Jakob Herrche} and Jesper Thaarup and Jesper Bjerre and Vejlstrup, {Niels Grove} and Klaus Juul and Stensballe, {Lone Graff}",
year = "2022",
month = jan,
doi = "10.1097/INF.0000000000003389",
language = "English",
volume = "41",
pages = "E25--E28",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams & Wilkins",
number = "1",
}
RIS
TY - JOUR
T1 - Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents
AU - Nygaard, Ulrikka
AU - Holm, Mette
AU - Bohnstedt, Cathrine
AU - Chai, Qing
AU - Schmidt, Lisbeth Samso
AU - Hartling, Ulla Birgitte
AU - Petersen, Jens Jakob Herrche
AU - Thaarup, Jesper
AU - Bjerre, Jesper
AU - Vejlstrup, Niels Grove
AU - Juul, Klaus
AU - Stensballe, Lone Graff
PY - 2022/1
Y1 - 2022/1
N2 - In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.
AB - In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.
KW - mRNA COVID-19 vaccine
KW - myopericarditis
KW - adolescents Accepted for publication October 10
KW - 2021
U2 - 10.1097/INF.0000000000003389
DO - 10.1097/INF.0000000000003389
M3 - Letter
C2 - 34889875
VL - 41
SP - E25-E28
JO - Pediatric Infectious Disease Journal
JF - Pediatric Infectious Disease Journal
SN - 0891-3668
IS - 1
ER -
